Cargando…
Preparation of pentagamaboronon-0 and its fructose and sorbitol complexes as boron carrier for boron neutron capture therapy (BNCT) application
Development of specific and selective boron carriers is indispensable for boron neutron capture therapy (BNCT) application. Pentagamaboronon-0 (PGB-0) is a promising candidate as boron carrier compound due to the low but selective cytotoxicity in breast cancer cells. Formerly we reported synthesis o...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714113/ https://www.ncbi.nlm.nih.gov/pubmed/31516505 http://dx.doi.org/10.4103/1735-5362.263552 |
_version_ | 1783446992256499712 |
---|---|
author | Susidarti, Ratna Asmah Utomo, Rohmad Yudi Qodria, Lailatul Ramadani, Ratna Dwi Ohta, Youichiro Hattori, Yoshihide Kirihata, Mitsunori Meiyanto, Edy |
author_facet | Susidarti, Ratna Asmah Utomo, Rohmad Yudi Qodria, Lailatul Ramadani, Ratna Dwi Ohta, Youichiro Hattori, Yoshihide Kirihata, Mitsunori Meiyanto, Edy |
author_sort | Susidarti, Ratna Asmah |
collection | PubMed |
description | Development of specific and selective boron carriers is indispensable for boron neutron capture therapy (BNCT) application. Pentagamaboronon-0 (PGB-0) is a promising candidate as boron carrier compound due to the low but selective cytotoxicity in breast cancer cells. Formerly we reported synthesis of PGB-0 which was ineffective due to its low aqueous solubility. In the present study, we, therefore, introduced the new PGB-0 preparation complexed with sugars to increase its solubility in water. By synthesizing at room temperature and using flash chromatography for the purification, we produced PGB-0 with a yield of 40%. PGB-0 fructose complex (PGB-0-F) and PGB-0 sorbitol complex (PGB-0-Sor) were obtained with smaller particle size compared to PGB-0 suspension in water. Based on the MTT assay, the cytotoxicity of PGB-0-F and PGB-0-Sor were higher than PGB-0 even though still categorized as low cytotoxic agents. In conclusion, we provided PGB-0 with a new method and improved its solubility in water. Further investigations are still needed to develop more efficient PGB-0 as boron carrier for BNCT in various cancers. |
format | Online Article Text |
id | pubmed-6714113 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-67141132019-09-12 Preparation of pentagamaboronon-0 and its fructose and sorbitol complexes as boron carrier for boron neutron capture therapy (BNCT) application Susidarti, Ratna Asmah Utomo, Rohmad Yudi Qodria, Lailatul Ramadani, Ratna Dwi Ohta, Youichiro Hattori, Yoshihide Kirihata, Mitsunori Meiyanto, Edy Res Pharm Sci Original Article Development of specific and selective boron carriers is indispensable for boron neutron capture therapy (BNCT) application. Pentagamaboronon-0 (PGB-0) is a promising candidate as boron carrier compound due to the low but selective cytotoxicity in breast cancer cells. Formerly we reported synthesis of PGB-0 which was ineffective due to its low aqueous solubility. In the present study, we, therefore, introduced the new PGB-0 preparation complexed with sugars to increase its solubility in water. By synthesizing at room temperature and using flash chromatography for the purification, we produced PGB-0 with a yield of 40%. PGB-0 fructose complex (PGB-0-F) and PGB-0 sorbitol complex (PGB-0-Sor) were obtained with smaller particle size compared to PGB-0 suspension in water. Based on the MTT assay, the cytotoxicity of PGB-0-F and PGB-0-Sor were higher than PGB-0 even though still categorized as low cytotoxic agents. In conclusion, we provided PGB-0 with a new method and improved its solubility in water. Further investigations are still needed to develop more efficient PGB-0 as boron carrier for BNCT in various cancers. Wolters Kluwer - Medknow 2019-08 /pmc/articles/PMC6714113/ /pubmed/31516505 http://dx.doi.org/10.4103/1735-5362.263552 Text en Copyright: © 2019 Research in Pharmaceutical Sciences http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Susidarti, Ratna Asmah Utomo, Rohmad Yudi Qodria, Lailatul Ramadani, Ratna Dwi Ohta, Youichiro Hattori, Yoshihide Kirihata, Mitsunori Meiyanto, Edy Preparation of pentagamaboronon-0 and its fructose and sorbitol complexes as boron carrier for boron neutron capture therapy (BNCT) application |
title | Preparation of pentagamaboronon-0 and its fructose and sorbitol complexes as boron carrier for boron neutron capture therapy (BNCT) application |
title_full | Preparation of pentagamaboronon-0 and its fructose and sorbitol complexes as boron carrier for boron neutron capture therapy (BNCT) application |
title_fullStr | Preparation of pentagamaboronon-0 and its fructose and sorbitol complexes as boron carrier for boron neutron capture therapy (BNCT) application |
title_full_unstemmed | Preparation of pentagamaboronon-0 and its fructose and sorbitol complexes as boron carrier for boron neutron capture therapy (BNCT) application |
title_short | Preparation of pentagamaboronon-0 and its fructose and sorbitol complexes as boron carrier for boron neutron capture therapy (BNCT) application |
title_sort | preparation of pentagamaboronon-0 and its fructose and sorbitol complexes as boron carrier for boron neutron capture therapy (bnct) application |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714113/ https://www.ncbi.nlm.nih.gov/pubmed/31516505 http://dx.doi.org/10.4103/1735-5362.263552 |
work_keys_str_mv | AT susidartiratnaasmah preparationofpentagamaboronon0anditsfructoseandsorbitolcomplexesasboroncarrierforboronneutroncapturetherapybnctapplication AT utomorohmadyudi preparationofpentagamaboronon0anditsfructoseandsorbitolcomplexesasboroncarrierforboronneutroncapturetherapybnctapplication AT qodrialailatul preparationofpentagamaboronon0anditsfructoseandsorbitolcomplexesasboroncarrierforboronneutroncapturetherapybnctapplication AT ramadaniratnadwi preparationofpentagamaboronon0anditsfructoseandsorbitolcomplexesasboroncarrierforboronneutroncapturetherapybnctapplication AT ohtayouichiro preparationofpentagamaboronon0anditsfructoseandsorbitolcomplexesasboroncarrierforboronneutroncapturetherapybnctapplication AT hattoriyoshihide preparationofpentagamaboronon0anditsfructoseandsorbitolcomplexesasboroncarrierforboronneutroncapturetherapybnctapplication AT kirihatamitsunori preparationofpentagamaboronon0anditsfructoseandsorbitolcomplexesasboroncarrierforboronneutroncapturetherapybnctapplication AT meiyantoedy preparationofpentagamaboronon0anditsfructoseandsorbitolcomplexesasboroncarrierforboronneutroncapturetherapybnctapplication |